All Products

Research Chemical Intermediates (29)

Research Chemicals BK MDMA (23)

Research Chemicals Methylone (23)

Research Chemical Powders (24)

Research Chemicals Crystal (19)

Dibutylone Crystal (16)

4 CMC Crystal (24)

BK EBDP (24)

APVP Research Chemical (5)

APVP Replacement (6)

2 NMC Chemical (11)

Pharmaceutical Intermediates (34)

Chemical Raw Materials (9)

MMBC Research Chemical (24)

Ascorbic Acid Powder (26)

Feed Additives (9)

Great Service Great Quality.

—— Carl Balfou

I appreciate you because you are so friendly and helpful. You really are a real pleasure to work with so polite and enjoyable to work with.

—— Jeff Rader

You are the sweetest, most caring service possible.

—— Luis Acosta

I'm Online Chat Now
skype mailto

Contact Now

Mavacoxib Pharmaceutical Intermediates , Pharmaceutical Chemicals CAS NO 170569-88-7

: Large Image : Mavacoxib Pharmaceutical Intermediates , Pharmaceutical Chemicals CAS NO 170569-88-7

Product Details:

Place of Origin:	China
Brand Name:	R&M
Certification:	ISO 9001, USP, GMP
Model Number:	01

Payment & Shipping Terms:

Minimum Order Quantity:	1g
Price:	negotiation
Packaging Details:	vaccum packing of aluminum foil bag

Contact Now

Detailed Product Description

ProName:	Mavacoxib	CasNo:	170569-88-7
Appearance:	Powder	Application:	Intermediates
PackAge:	Standard Or As Customer's Require	Storage:	Dry And Ventilated

Mavacoxib
Clinical data

Trade names	Trocoxil
AHFS/Drugs.com	International Drug Names
ATCvet code	QM01AH92 (WHO)
Identifiers
CAS Number	170569-88-7
PubChem CID	9843089
ChemSpider	8018804
UNII	YFT7X7SR77
ChEBI	CHEBI:76207
Chemical and physical data
Formula	C₁₆H₁₁F₄N₃O₂S
Molar mass	385 g/mol
3D model (JSmol)	Interactive image
SMILES[hide] C1=CC(=CC=C1C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F)F
InChI[hide] InChI=1S/C16H11F4N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25) Key:TTZNQDOUNXBMJV-UHFFFAOYSA-N

Mavacoxib (trade name Trocoxil) is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease. It acts as a COX-2 inhibitor.

Mavacoxib, along with other COX-2 selective inhibitors, celecoxib, valdecoxib, and parecoxib, were discovered by a team at the Searle division of Monsanto led by John Talley.

Tag:

bulk drug intermediates,

bulk pharmaceutical chemicals

Contact Details

Fanchuang Medical Biotechnology Co., Ltd.

Contact Person: admin

Other Products

Select Language